The world market for diagnostics was about $54.6 billion in 2013 and is expected to grow 4% annually, to $65 billion, by 2018.
That figure in Kalorama's biennial survey of the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition, includes all laboratory and hospital-based products, and OTC product sales. New technology is leading the charge, according to Kalorama. Diagnostic laboratory technology has changed dramatically due to the publication of the human genome project and advances in functional genomics, bioinformatics, miniaturization and microelectronics.
"Not three years ago it would have been almost inconceivable to see research technologies such as genome sequencing and mass spectroscopy play a pivotal role in improving lab medicine," said Shara Rosen, Kalorama's lead diagnostic analyst and the author of the report. "Their influence is felt in personalized medicine, inherited diseases, pathogen detection, antibiotic resistance testing, blood banking and much more to come."
According to the report, this phenomenon has seen the major vendors of these technologies enter the IVD market. Life Technologies, Illumina, Affymetrix, Bruker Daltonics, PerkinElmer/Caliper and others have all launched clinical tests and test services. Another finding in the report is that emerging markets have taken off. All of the major IVD companies reported at least 25% increase in their sales in China and growth in the top seven emerging markets: Brazil, Turkey, Korea, India, Russia and Mexico.
"We knew that these were target markets but the double-digit results in China were surprising," said Bruce Carlson, Publisher of Kalorama Information. "These countries continue to invest in healthcare infrastructure and insurance coverage and IVD is part of that."
On the supply side, labs are challenged to add new tests with little increase in financial and human resources. For most labs it may even mean doing more with less.
The survey can be obtained at http://www.kaloramainformation.com/redirect.asp?progid=86544&productid=8...
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Thinking 'I Can Do Better' Really Can Improve Performance, Study Finds
- Brain Cancer: Why Glioblastoma Is So Difficult To Treat
- Some Celiac Disease May Be Due To Viruses
- Can A New Rule Trigger A Second EU Referendum? Petition 4 Millon Signatures, Nearly 12% Of Total Votes Cast
- How A Former Naturopath Can Help Unravel The Trickery of Alternative Medicine
- Little To No Association Between Butter Consumption And Chronic Disease Or Total Mortality
- Out Of Africa: What They Do Not Tell Us
- " Media Silent as Concealed Carrier Stops Mass Shooting in Progress at a South Carolina Nightclub..."
- "Thank you for your support - but since the comment you refer to was advocating the shutting down..."
- "Instead of ND, substitute DD, and you have a whole other basket of charlatans - and that comment..."
- " Some parts from my second response to Nina Teicholz article ( http://www.bmj.com/content/351/bmj..."
- "Science researchers did the CARET study, to see if vitamin A could chemo-prevent lung cancer (it..."
- The Relationship Between Alcohol and Happiness
- Psst…NRDC Stoners: Your Endocrines Are Disrupted
- College Kids Mostly Blow Off Food-Label Use, Study Finds
- Blue Birds Aren’t Blue, and This is How They Fool You
- ‘Vaxxed’: The Film That No One Saw
- Vice President Joe Biden Threatens the Scientific Community
- Consensus statement: Environmental toxins hurt brain development, action needed
- New anti-cancer strategy mobilizes both innate and adaptive immune response
- Aging population is growing ranks of cancer survivors
- UK government should fund media campaigns that promote quitting, not films that promote smoking
- Report: A host of common chemicals endanger child brain development